Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) — Financial Flexibility Index
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (600332) has a Financial Flexibility Index of 0.05x as of December 2025. Free cash flow of CN¥2.18 Billion (operating CF CN¥1.84 Billion minus capex CN¥330.65 Million) represents 0% of total liabilities (CN¥43.39 Billion). Also explore how fast is Guangzhou Baiyunshan Pharmaceutical Hold growing its equity to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Financial Flexibility Index (2000–2025)
Historical Financial Flexibility Index trend for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd across 26 annual periods. Check how strategically is Guangzhou Baiyunshan Pharmaceutical Hold's equity deployed to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (2000–2025)
Year-by-year free cash flow to debt coverage for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd. For the full company profile including market capitalisation, see how much is Guangzhou Baiyunshan Pharmaceutical Hold worth.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.03x | CN¥1.50 Billion | CN¥260.23 Million | CN¥43.39 Billion | ▼ -66.8% |
| 2024 | 0.10x | CN¥4.57 Billion | CN¥3.44 Billion | CN¥43.91 Billion | ▼ -23.9% |
| 2023 | 0.14x | CN¥5.73 Billion | CN¥4.10 Billion | CN¥41.91 Billion | ▼ -33.1% |
| 2022 | 0.20x | CN¥8.38 Billion | CN¥7.00 Billion | CN¥41.03 Billion | ▲ +2.6% |
| 2021 | 0.20x | CN¥6.93 Billion | CN¥5.67 Billion | CN¥34.79 Billion | ▲ +329.9% |
| 2020 | 0.05x | CN¥1.46 Billion | CN¥585.19 Million | CN¥31.55 Billion | ▼ -80.7% |
| 2019 | 0.24x | CN¥7.42 Billion | CN¥5.02 Billion | CN¥30.90 Billion | ▲ +19.5% |
| 2018 | 0.20x | CN¥5.70 Billion | CN¥5.22 Billion | CN¥28.34 Billion | ▼ -10.4% |
| 2017 | 0.22x | CN¥2.03 Billion | CN¥1.83 Billion | CN¥9.05 Billion | ▼ -30.8% |
| 2016 | 0.32x | CN¥2.67 Billion | CN¥2.44 Billion | CN¥8.24 Billion | ▼ -5.2% |
| 2015 | 0.34x | CN¥2.46 Billion | CN¥1.94 Billion | CN¥7.19 Billion | ▲ +1.1% |
| 2014 | 0.34x | CN¥2.12 Billion | CN¥1.76 Billion | CN¥6.25 Billion | ▲ +4.7% |
| 2013 | 0.32x | CN¥1.69 Billion | CN¥1.34 Billion | CN¥5.23 Billion | ▲ +16.3% |
| 2012 | 0.28x | CN¥559.14 Million | CN¥506.53 Million | CN¥2.01 Billion | ▲ +319.3% |
| 2011 | -0.13x | CN¥-121.19 Million | CN¥-180.05 Million | CN¥956.09 Million | ▼ -167.7% |
| 2010 | 0.19x | CN¥156.37 Million | CN¥73.17 Million | CN¥835.05 Million | ▼ -70.8% |
| 2009 | 0.64x | CN¥526.95 Million | CN¥439.39 Million | CN¥820.92 Million | ▲ +337.0% |
| 2008 | 0.15x | CN¥133.09 Million | CN¥6.10 Million | CN¥905.99 Million | ▼ -14.2% |
| 2007 | 0.17x | CN¥498.43 Million | CN¥375.74 Million | CN¥2.91 Billion | ▲ +224.9% |
| 2006 | 0.05x | CN¥129.33 Million | CN¥38.88 Million | CN¥2.46 Billion | ▼ -55.4% |
| 2005 | 0.12x | CN¥270.68 Million | CN¥146.32 Million | CN¥2.29 Billion | ▼ -40.9% |
| 2004 | 0.20x | CN¥509.23 Million | CN¥200.54 Million | CN¥2.55 Billion | ▲ +17.1% |
| 2003 | 0.17x | CN¥360.35 Million | CN¥-6.83 Million | CN¥2.11 Billion | ▼ -12.8% |
| 2002 | 0.20x | CN¥342.71 Million | CN¥169.01 Million | CN¥1.75 Billion | ▼ -7.9% |
| 2001 | 0.21x | CN¥300.59 Million | CN¥140.15 Million | CN¥1.41 Billion | ▼ -26.1% |
| 2000 | 0.29x | CN¥450.48 Million | CN¥286.95 Million | CN¥1.57 Billion | — |